This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Jessica Rachel Molek: Innovator in Antibody Purification
Introduction
Jessica Rachel Molek is a prominent inventor based in King of Prussia, PA (US). She has made significant contributions to the field of biotechnology, particularly in the purification of antibodies. Her innovative methods are paving the way for advancements in therapeutic applications.
Latest Patents
Jessica holds a patent for "Methods for purifying antibodies." This invention relates to a method of purifying a recombinant polypeptide from Host Cell Proteins (HCP). The method involves applying a solution containing the recombinant polypeptide and HCP to a superantigen chromatography solid support. It includes washing the support with a wash buffer comprising caprylate and arginine, followed by eluting the recombinant polypeptide from the solid support. This patent showcases her expertise and dedication to improving biopharmaceutical processes. She has 1 patent to her name.
Career Highlights
Jessica is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where she continues to innovate and contribute to the field. Her work focuses on enhancing the efficiency of antibody purification processes, which is crucial for the development of effective therapies.
Collaborations
Jessica has collaborated with notable colleagues, including Andre C Dumetz and Kent E Goklen. These partnerships have further enriched her research and development efforts in the biotechnology sector.
Conclusion
Jessica Rachel Molek is a trailblazer in the field of antibody purification, with her innovative methods significantly impacting biopharmaceutical development. Her contributions are vital for advancing therapeutic solutions in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
